Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-28.92	-343.06	482.65
Graham Fair Price	23.09	77.85	63.25
PEG	-64.63	0.16	-0.44
Price/Book	10.81	1.17	1.05
Price/Cash Flow	193.89	72.34	24.61
Prices/Earnings	-26.44	8.46	11.50
Price/Sales	5.70	6.70	6.34
Price/FCF	193.89	72.34	24.61
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.80	0.85	0.89
Operating Margin	1676.85	0.28	0.02
ROA	48.21	< 0.005	< 0.005
ROE	0.02	0.03	50.65
ROIC	< 0.005	0.02	1724.85
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.08	< 0.005	14277.88
Dividends QOQ	< 0.005	0.08	2846.47
EBIT QOQ	0.02	17.76	82221.79
EPS QOQ	-0.26	0.54	107.94
FCF QOQ	2.38	-0.62	-73.88
Revenue QOQ	0.56	0.06	-90.06
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-1610.89	-1270.82	21.11
Days Sales Outstanding (DSO)	226.31	151.63	-33.00
Inventory Turnover	-0.06	-0.07	-26.76
Debt/Capitalization	0.41	0.42	3.36
Quick Ratio	0.22	0.21	-0.61
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	88.18	88.42	0.28
Cash	94.70	108.75	14.84
Capex	-0.28	-0.17	38.58
Free Cash Flow	3.77	1.42	-62.19
Revenue	14.63	15.38	5.13
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.09	0.07	-14.67
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	81.60	-63.26	-22.47
Naive Interpretation	Member

06 - Financial Health · Bad

Rating